2014 Annual Meeting | 2FC.002 - Neurologic Intensive Care

Date Sunday 04/27/14

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Alejandro A. Rabinstein, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the management of a variety of acute neurocritical care disorders, with an emphasis on the fundamental principles of primary and secondary brain injury, and gain an enhanced understanding of both pathophysiology and practical care issues. The lectures will include information on diagnosis, treatment, and prognosis. Participants should also gain insight into the application and interpretation of new monitoring techniques for the various conditions discussed.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic

Event Timeline
09:00 AM - 09:05 AM		Introduction Alejandro A. Rabinstein, MD, FAAN
09:05 AM - 09:50 AM		Critical Care of Ischemic Stroke Wade S. Smith, MD, PhD
09:50 AM - 09:55 AM		Questions and Answers Wade S. Smith, MD, PhD
09:55 AM - 10:40 AM		Contemporary Management of Intracerebral Hemorrhage Edward M. Manno, MD, FAAN
10:40 AM - 10:45 AM		Questions and Answers Edward M. Manno, MD, FAAN
10:45 AM - 11:00 AM		Break
11:00 AM - 11:45 AM		Neurocritical Care of Subarachnoid Hemorrhage Alejandro A. Rabinstein, MD, FAAN
11:45 AM - 11:50 AM		Questions and Answers Alejandro A. Rabinstein, MD, FAAN
11:50 AM - 12:00 PM		Discussion
12:00 PM - 01:00 PM		Lunch Break
01:00 PM - 01:45 PM		Recovery from Traumatic Brain Injury Robert Stevens
01:45 PM - 01:50 PM		Questions and Answers Robert Stevens
01:50 PM - 02:35 PM		Acute Neuromuscular Respiratory Failure Eelco F. Wijdicks, MD, FAAN
02:35 PM - 02:40 PM		Questions and Answers Eelco F. Wijdicks, MD, FAAN
02:40 PM - 02:55 PM		Break
02:55 PM - 03:40 PM		Treatment Options for Refractory Status Epilepticus Thomas P. Bleck, MD, FAAN
03:40 PM - 03:45 PM		Questions and Answers Thomas P. Bleck, MD, FAAN
03:45 PM - 04:30 PM		Prognostication and Withdrawal of Life Support Therapy: When Is It Time to Let Go? Stephan A. Mayer, MD
04:30 PM - 04:35 PM		Questions and Answers Stephan A. Mayer, MD
04:35 PM - 05:00 PM		Discussion

Faculty Disclosures
Thomas P. Bleck, MD, FAAN	Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH.
Eelco F. Wijdicks, MD, FAAN	Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Stephan A. Mayer, MD	Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Wade S. Smith, MD, PhD	Dr. Smith has stock in MindRhythm, Inc. The institution of Dr. Smith has received research support from NIH. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Edward M. Manno, MD, FAAN	No disclosure on file
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Robert Stevens	No disclosure on file

��ɫ��

��ɫ��